COMPUGEN REORGANIZES, PLANS 25% CUT TO WORKFORCE

Compugen (Nasdaq: CGEN; TASE: CGEN) today announced organizational changes to support its development and commercialization plans for 2006 and 2007. The company is being reorganized into three operating units: a therapeutics business unit, a diagnostic biomarkers business unit, and a research and discovery unit. The key driver for these organizational changes has been Compugen's desire to focus all resources and activities on short and mid-term development and commercialization goals.

Globes Online (http://www.globes.co.il/serveen/globes/docview.asp?did=1000035976&fid=942)